US Preventive Services Task Force Issues Final Recommendation on BRCA-Related Cancer Prevention
Some women may benefit from risk assessment, counseling, and testing for rare genetic mutations, says USPSTF.
Read MoreSearch Results for: prostate cancer
Liquid Biopsies Guide Improved Cancer Treatment
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read MoreAstraZeneca, Merck, and Myriad Expand Partnership for Cancer Diagnostics Research
Myriad’s BRACAnalysis companion diagnostic will be used to identify germline BRCA mutations in men with metastatic castration-resistant prostate cancer.
Read More
Myriad Supports New Guidelines Recommending Genetic Testing for Those with Breast Cancer
Study data demonstrate that about half of patients have clinically actionable mutations that are being missed.
Read More
National Cancer Institute Grants Support Liquid Biopsy Studies
With three NCI grants, BioFluidica is investigating chip-based liquid biopsy technologies for the detection of cancer and related genetic variants.
Read More